Kenneth T. Mills serves as Executive at REGENXBIO Inc., where they oversee executive responsibilities. Since joining the company, Kenneth T. Mills has executed 158 insider transactions totaling $25.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 21, 2017 involved selling 6,500 shares valued at $130.3K.
Kenneth T. Mills currently holds 444,351 shares of REGENXBIO Inc. (RGNX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kenneth T. Mills has been a net seller of RGNX stock. They have purchased $0 and sold $25.6M worth of shares.
Kenneth T. Mills's most recent insider trade was on Aug 21, 2017, when they sold 6,500 shares at $20.05 per share.
Get notified when new Form 4 filings are submitted
| $18.66 |
| Discretionary |
| Jun 20, 2017 | RGNX | $109.8K | Sale | 5,604 | $19.60 | Discretionary |
| Jun 20, 2017 | RGNX | $18.1K | Sale | 896 | $20.16 | Discretionary |
| Apr 24, 2017 | RGNX | $294.1K | Sale | 14,045 | $20.94 | Discretionary |
| Apr 24, 2017 | RGNX | $29.9K | Sale | 1,395 | $21.40 | Discretionary |
| Jun 13, 2016 | RGNX | $106.3K | Option Exercise | 125,000 | $0.85 | Discretionary |
| Sep 22, 2015 | RGNX | $0 | Conversion | 15,440 | $N/A | Discretionary |